594
Views
7
CrossRef citations to date
0
Altmetric
Thematic Issue: 52nd International Conference on the Bioscience of Lipids

Influence of liver-X-receptor on tissue cholesterol, coenzyme Q and dolichol content

, , , , , & show all
Pages 299-308 | Received 16 Feb 2012, Accepted 04 May 2012, Published online: 14 Jun 2012

References

  • Aberg F, Zhang Y, Appelkvist EL, Dallner G. 1994. Effects of clofibrate, phthalates and probucol on ubiquinone levels. Chem Biol Interact 91:1–14.
  • Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, 2001. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest 107:565–573.
  • Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, 2004. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201–1204.
  • Barbier O, Trottier J, Kaeding J, Caron P, Verreault M. 2009. Lipid-activated transcription factors control bile acid glucuronidation. Mol Cell Biochem 326:3–8.
  • Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, 2008. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97–111.
  • Bentinger M, Brismar K, Dallner G. 2007. The antioxidant role of coenzyme Q. Mitochondrion 7(Suppl):S41–S50.
  • Bentinger M, Dallner G, Chojnacki T, Swiezewska E. 2003a. Distribution and breakdown of labeled coenzyme Q10 in rat. Free Radic Biol Med 34:563–575.
  • Bentinger M, Tekle M, Brismar K, Chojnacki T, Swiezewska E, Dallner G. 2008. Polyisoprenoid epoxides stimulate the biosynthesis of coenzyme Q and inhibit cholesterol synthesis. J Biol Chem 283:14645–14653.
  • Bentinger M, Tekle M, Dallner G. 2010. Coenzyme Q – biosynthesis and functions. Biochem Biophys Res Commun 396:74–79.
  • Bentinger M, Turunen M, Zhang XX, Wan YJ, Dallner G. 2003b. Involvement of retinoid X receptor alpha in coenzyme Q metabolism. J Mol Biol 326:795–803.
  • Calkin AC, Tontonoz P. 2010. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 30:1513–1518.
  • Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, Clavey V, 2006. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun 340:1259–1263.
  • Echtay KS, Winkler E, Frischmuth K, Klingenberg M. 2001. Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc Natl Acad Sci USA 98:1416–1421.
  • Edwards PA, Ericsson J. 1999. Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68:157–185.
  • Eggens I, Elmberger PG, Low P. 1989. Polyisoprenoid, cholesterol and ubiquinone levels in human hepatocellular carcinomas. Br J Exp Pathol 70:83–92.
  • Ericsson J, Appelkvist EL, Thelin A, Chojnacki T, Dallner G. 1992. Isoprenoid biosynthesis in rat liver peroxisomes. Characterization of cis-prenyltransferase and squalene synthetase. J Biol Chem 267:18708–18714.
  • Ernster L, Orrenius S. 1973. Dynamic organization of endoplasmic reticulum membranes. Drug Metab Dispos 1:66–73.
  • Fan X, Kim HJ, Bouton D, Warner M, Gustafsson JA. 2008. Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of later-born neurons. Proc Natl Acad Sci USA 105:13445–13450.
  • Folkers K, Vadhanavikit S, Mortensen SA. 1985. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA 82:901–904.
  • Forsmark-Andree P, Lee CP, Dallner G, Ernster L. 1997. Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles. Free Radic Biol Med 22:391–400.
  • Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343:425–430.
  • Grunler J, Ericsson J, Dallner G. 1994. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim Biophys Acta 1212:259–277.
  • Guan Z, Soderberg M, Sindelar P, Prusiner SB, Kristensson K, Dallner G. 1996. Lipid composition in scrapie-infected mouse brain: Prion infection increases the levels of dolichyl phosphate and ubiquinone. J Neurochem 66:277–285.
  • Kalen A, Appelkvist EL, Dallner G. 1989. Age-related changes in the lipid compositions of rat and human tissues. Lipids 24:579–584.
  • Kornfeld R, Kornfeld S. 1985. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631–664.
  • Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, 2009. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res 50:312–326.
  • Littarru GP, Tiano L. 2010. Clinical aspects of coenzyme Q10: An update. Nutrition 26:250–254.
  • Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, 2006. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113:90–97.
  • Papucci L, Schiavone N, Witort E, Donnini M, Lapucci A, Tempestini A, 2003. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem 278:28220–28228.
  • Quinzii CM, Lopez LC, Naini A, Dimauro S, Hirano M. 2008. Human CoQ10 deficiencies. Biofactors 32:113–118.
  • Schaefer JR. 2011. Lipid management for the prevention of cardiovascular disease. Curr Pharm Des 17:852–860.
  • Schmelzer C, Lindner I, Vock C, Fujii K, Doring F. 2007. Functional connections and pathways of coenzyme Q10-inducible genes: An in-silico study. IUBMB Life 59:628–633.
  • Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. 1992. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem 59:1646–16453.
  • Song C, Hiipakka RA, Liao S. 2000. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 65:423–427.
  • Swiezewska E, Danikiewicz W. 2005. Polyisoprenoids: Structure, biosynthesis and function. Prog Lipid Res 44:235–258.
  • Tollbom O, Chojnacki T, Dallner G. 1989. Hydrolysis of dolichyl esters by rat liver lysosomes. J Biol Chem 264:9836–9841.
  • Turunen M, Olsson J, Dallner G. 2004. Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660:171–199.
  • Turunen M, Peters JM, Gonzalez FJ, Schedin S, Dallner G. 2000. Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis. J Mol Biol 297:607–614.
  • Van Den Bosch H, Schutgens RB, Wanders RJ, Tager JM. 1992. Biochemistry of peroxisomes. Annu Rev Biochem 61:157–197.
  • Wang Y, Rogers PM, Su C, Varga G, Stayrook KR, Burris TP. 2008. Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J Biol Chem 283:26332–26339.
  • Watanabe Y, Jiang S, Takabe W, Ohashi R, Tanaka T, Uchiyama Y, 2005. Expression of the LXRalpha protein in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 25:622–627.
  • Zhao C, Dahlman-Wright K. 2010. Liver X receptor in cholesterol metabolism. J Endocrinol 204:233–240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.